Terminated PHASE3 INTERVENTIONAL NCT00005015

Treatment of Depression in Youth With Bipolar Disorders

Fluoxetine for the Treatment of Major Depression in Youth With Bipolar Disorder _

Sponsor: National Institute of Mental Health (NIMH)

Interventions Fluoxetine

Updated 5 times since 2017 Last updated: Nov 17, 2005 Completion: Sep 30, 2000

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

This trial was terminated. No reason was provided.

Other terminated trials from National Institute of Mental Health (NIMH)

See all terminations from National Institute of Mental Health (NIMH)

Other Bipolar Disorder trials with similar outcome

Browse all Bipolar Disorder trials

Listed as NCT00005015, this PHASE3 trial focuses on Bipolar Disorder and Depression and remains terminated or withdrawn. Sponsored by National Institute of Mental Health (NIMH), it has been updated 5 times since 2026, reflecting limited change activity. Mental health research at this phase helps define safety and dosing parameters for future study.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Terminated PHASE3
Jul 2024 — Sep 2024 [monthly]

Terminated PHASE3
Jan 2021 — Jul 2024 [monthly]

Terminated PHASE3
Jun 2018 — Jan 2021 [monthly]

Terminated PHASE3
Jan 2017 — Jun 2018 [monthly]

Terminated PHASE3

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

National Institute of Mental Health (NIMH)

Data source: National Institute of Mental Health (NIMH)

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.